Anthrax: Safe treatment for children

Annals of Pharmacotherapy

Volumn 36, Issue 2, 2002, Pages 334-337

  Benavides, Sandra ^a   Nahata, Milap C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Anthrax; Ciprofloxacin; Doxycycline; Fluoroquinolones

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC THERAPY; ARTHRALGIA; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CHILD CARE; CHONDROPATHY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG SAFETY; HUMAN; INFECTION RISK; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOOTH COLOR; TOOTH DISEASE;

ANTHRAX; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACILLUS ANTHRACIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CIPROFLOXACIN; DOXYCYCLINE; HUMANS; PRACTICE GUIDELINES; UNITED STATES;

EID: 0036159235     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A424     Document Type: Review

References (35)

1. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
2. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
3. Update interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax, November 2001
4. Chemical-biological terrorism and its impact on children: A subject review (RE9959)
5. Anthrax
6. Anthrax
7. Recognition and management of anthrax an update
8. Postexposure prophylaxis against experimental inhalation anthrax
9. Penicillin therapy of human cutaneous anthrax
10. The incidence of staining of permanent teeth by the tetracyclines
11. Miscellaneous antimicrobial drugs: Sulfonamides and trimethoprim, tetracycline, other antimicrobial drugs
12. Bone localization of the tetracyclines
13. Tetracyclines and permanent teeth: The relation between dose and tooth color
14. Discoloration of permanent teeth and enamel hypoplasia due to tetracycline
15. Enamel staining and hypoplasia due to multiple causes in a Nigerian adolescent: Report of a case
16. Tetracycline-induced tooth changes. Part 5. Incidence in extracted first permanent molar teeth: A resurvey after four years
17. Doxycycline and the teeth
18. Penicillins, cephalosporins and tetracyclines
19. Doxycycline and staining of permanent teeth
20. Some pharmacokinetic aspects of doxycycline metabolism in man
21. Growth inhibition of prematures receiving tetracycline
22. Specific toxicologic aspects of the quinolones
23. Quinolone arthropathy in animals versus children
24. Ciprofloxacin in pediatrics: Worldwide clinical experience based on compassionate use safety report
25. Pathogenesis and management of arthropathy in cystic fibrosis
26. Ciprofloxacin safety in a pediatric population
27. Quinolones in clinical use
28. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin
29. Cystic fibrosis and drug-induced arthropathy
30. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia
31. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin
32. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients